HUMAN PERIPHERAL-BLOOD CD4(+) AND CD8(+) T-CELLS EXPRESS TH1-LIKE CYTOKINE MESSENGER-RNA AND PROTEINS FOLLOWING IN-VITRO STIMULATION WITH HEAT-INACTIVATED BRUCELLA-ABORTUS

被引:60
作者
ZAITSEVA, MB
GOLDING, H
BETTS, M
YAMAUCHI, A
BLOOM, ET
BUTLER, LE
STEVAN, L
GOLDING, B
机构
[1] US FDA, CTR BIOL EVALUAT & RES, DIV HEMATOL, PLASMA DERIVAT LAB, BETHESDA, MD 20892 USA
[2] US FDA, CTR BIOL EVALUAT & RES, DIV VIRAL PROD, RETROVIRUS RES LAB, BETHESDA, MD 20892 USA
[3] US FDA, CTR BIOL EVALUAT & RES, DIV CELL & GENE THERAPY, CELLULAR IMMUNOL LAB, BETHESDA, MD 20892 USA
关键词
D O I
10.1128/IAI.63.7.2720-2728.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Defining the pattern of lymphokine production associated with Brucella abortus is critical for advancing the development of B. abortus as a vaccine carrier. In the present study we investigated the ability of heat-inactivated B. abortus or lipopolysaccharide from B. abortus to induce lymphokine production from purified human T cells in vitro, Gamma interferon (IFN-gamma), interleukin-2 (IL-2), IL-4, and IL-5 induction was assayed by mRNA-specific PCR and by enzyme-linked immunosorbent assay and bioassay for protein production, Following depletion of monocytes and B cells, B. abortus increased IFN-gamma and IL-2 mRNA expression in purified T cells compared with expression in unstimulated cells. In contrast, no IL-5 mRNA expression and only transient low-level IL-4 mRNA expression and no IL-4 protein secretion were detected. Phytohemagglutinin or phorbol myristate acetate plus ionomycin induced mRNA and protein for all these cytokines. Similar results were obtained with LPS purified from B. abortus. Removal of NK cells did not reduce lymphokine production, and enriched NK cells did not express IFN-gamma mRNA or secrete IFN-gamma protein in response to B. abortus, indicating that NK cells were not the responding population, Both CD4(+) and CD8(+) populations produced IFN-gamma and IL-2 in response to B. abortus. Preincubation of resting T cells with B. abortus or LPS from B. abortus for 7 days induced their differentiation into Th1-like cells as judged by their subsequent lymphokine response to phorbol myristate acetate plus ionomycin. These results suggest that B. abortus con induce differentiation of Th0 into Th1-type cells.
引用
收藏
页码:2720 / 2728
页数:9
相关论文
共 54 条
[1]   LIPOPOLYSACCHARIDE FROM BRUCELLA-ABORTUS BEHAVES AS A T-CELL-INDEPENDENT TYPE-1 CARRIER IN MURINE ANTIGEN-SPECIFIC ANTIBODY-RESPONSES [J].
BETTS, M ;
BEINING, P ;
BRUNSWICK, M ;
INMAN, J ;
ANGUS, RD ;
HOFFMAN, T ;
GOLDING, B .
INFECTION AND IMMUNITY, 1993, 61 (05) :1722-1729
[2]   BRUCELLA-ABORTUS STIMULATES HUMAN T-CELLS FROM UNINFECTED AND HIV-INFECTED INDIVIDUALS TO SECRETE IFN-GAMMA - IMPLICATIONS FOR USE OF BRUCELLA-ABORTUS AS A CARRIER IN DEVELOPMENT OF HUMAN VACCINES [J].
BLAY, R ;
HERNANDEZ, D ;
BETTS, M ;
CLERICI, M ;
LUCEY, DR ;
HENDRIX, C ;
HOFFMAN, T ;
GOLDING, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (04) :479-486
[3]   THE ROLE OF CACHECTIN/TNF IN ENDOTOXIC-SHOCK AND CACHEXIA [J].
CERAMI, A ;
BEUTLER, B .
IMMUNOLOGY TODAY, 1988, 9 (01) :28-31
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765
[6]  
DADDARIO M, 1992, J IMMUNOL, V148, P1222
[7]   BIOLOGY OF INTERLEUKIN-1 [J].
DINARELLO, CA .
FASEB JOURNAL, 1988, 2 (02) :108-115
[8]   DIFFERENTIATION OF T-CELL LYMPHOKINE GENE-EXPRESSION - THE INVITRO ACQUISITION OF T-CELL MEMORY [J].
EHLERS, S ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :25-36
[9]   MECHANISM OF INHIBITION OF HSV-1 REPLICATION BY TUMOR-NECROSIS-FACTOR AND INTERFERON-GAMMA [J].
FEDUCHI, E ;
CARRASCO, L .
VIROLOGY, 1991, 180 (02) :822-825
[10]  
FINKELMAN FD, 1988, J IMMUNOL, V140, P1022